Financhill
Back

Madrigal Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

MDGL
Madrigal Pharmaceuticals, Inc.

Last Price:
$431.54
Seasonality Move:
-8.32%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.

Madrigal Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 475.28 Sell
20-day SMA: 482.63 Sell
50-day SMA: 526.21 Sell
200-day SMA: 421.32 Buy
8-day EMA: 471.9 Sell
20-day EMA: 485.16 Sell
50-day EMA: 504.05 Sell
200-day EMA: 444.82 Sell

Madrigal Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -15.22 Sell
Relative Strength Index (14 RSI): 32.7 Sell
Chaikin Money Flow: -575249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (471.15 - 501.45) Sell
Bollinger Bands (100): (446.38 - 564.58) Sell

Madrigal Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Madrigal Pharmaceuticals, Inc. Stock

Is Madrigal Pharmaceuticals, Inc. Stock a Buy?

MDGL Technical Analysis vs Fundamental Analysis

Sell
40
Madrigal Pharmaceuticals, Inc. (MDGL) is a Sell

Is Madrigal Pharmaceuticals, Inc. a Buy or a Sell?

Madrigal Pharmaceuticals, Inc. Stock Info

Market Cap:
9.9B
Price in USD:
436.87
Share Volume:
1.2M

Madrigal Pharmaceuticals, Inc. 52-Week Range

52-Week High:
615.00
52-Week Low:
265.00
Sell
40
Madrigal Pharmaceuticals, Inc. (MDGL) is a Sell

Madrigal Pharmaceuticals, Inc. Share Price Forecast

Is Madrigal Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Madrigal Pharmaceuticals, Inc.

Is Madrigal Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $3.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.17 per share, and an increase next year of $14.50 per share.

Technical Analysis of Madrigal Pharmaceuticals, Inc.

Should I short Madrigal Pharmaceuticals, Inc. stock?

* Madrigal Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.